Post by Parth Narlawar

I’m pleased to share the publication of our paper, “Consistency and clarity of pharmacogenomic guidance in UK medicine patient information leaflets: A cross-sectional analysis,” in the British Journal of Clinical Pharmacology. This study examines how Pharmacogenomic (PGx) guidance is presented in UK Patient Information Leaflets (PIL) and highlights variation in the consistency and clarity of the information provided to patients. Additionally, this paper identifies the large discrepancy and variability in the readability of PGx information when compared to the rest of the PIL. As pharmacogenomics moves closer to front-line care, it is essential that both physicians and patients are adequately informed when making decisions about their health. This paper helps evaluate the current landscape and provides indications for where regulatory work is needed. This project forms part of a wider initiative under CERSI- PGx, led by the University of Liverpool, to accelerate the adoption of pharmacogenomics in the UK. In particular, this work forms part of Work Package 5 led by Dr John McDermott and Dr Ramona Moldovan to integrate patient and public voices into regulatory decision-making. I’d like to thank William Newman for the wonderful opportunity and Dr John McDermott for all their guidance throughout the project. Read the full paper here: https://lnkd.in/e2vPQpwH